[Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
作者信息
Mertz D P, Sulzberger I, Klöpfer M
出版信息
Munch Med Wochenschr. 1970 Feb 6;112(6):241-7.
PMID:5537894
Abstract
摘要
相似文献
1
[Diabetes mellitus, hyperlipemia, fatty liver, hypertension in primary gout and their influencing by benzbromaronum].
Munch Med Wochenschr. 1970 Feb 6;112(6):241-7.
2
[Liver pathology in gout].
Med Klin. 1971 May 21;66(21):777-81.
3
[Alterations of lipid metabolism in primary gout and hyperuircemia].
Dtsch Med Wochenschr. 1971 Mar 19;96(12):488-93. doi: 10.1055/s-0028-1108280.
4
[Benziodarone in the basic treatment of gout].
Rev Rhum Mal Osteoartic. 1972 Jan;39(1):33-9.
5
[Gout, diabetes mellitus and fatty liver].
Munch Med Wochenschr. 1972 Feb 4;114(5):180-5.
6
[Current problems of gout].
Z Gesamte Inn Med. 1970 May 15;25(10):458-63.
7
[Gout in young subjects].
Minerva Med. 1977 Mar 30;68(15):985-90.
8
[Changes in the serum concentration of uric acid under the effect of benzbromaronum].
Munch Med Wochenschr. 1969 Feb 28;111(9):491-5.
9
[Changes between 1948 and 1970 in the epidemiology and clinical features of primary gout].
Dtsch Med Wochenschr. 1973 Feb 2;98(5):183-8. doi: 10.1055/s-0028-1106774.
10
[Effect of allopurinol (Zyloric) on uric acid, creatinine, fasting blood sugar and plasma lipids in patients with gout].
Wien Klin Wochenschr. 1970 Jan 30;82(5):78-82.
引用本文的文献
1
Benzbromarone: a review of its pharmacological properties and therapeutic use in gout and hyperuricaemia.
Drugs. 1977 Nov;14(5):349-66. doi: 10.2165/00003495-197714050-00002.
Zotero 插件